FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

359133006: Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    473283018 Galactose microparticles+palmitic acid 2497.5mg/2.5mg granules+diluent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1457647013 Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1478040014 Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4722451000005118 galaktosemikropartikler 2497,5 mg + palminsyre 2,5 mg pulver og opløsningsmiddel til hætteglas med injektionsvæske, suspension da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    galaktosemikropartikler 2497,5 mg + palminsyre 2,5 mg pulver og opløsningsmiddel til hætteglas med injektionsvæske, suspension Is a galaktosemikropartikler false Inferred relationship Some
    galaktosemikropartikler 2497,5 mg + palminsyre 2,5 mg pulver og opløsningsmiddel til hætteglas med injektionsvæske, suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Galactose false Inferred relationship Some
    galaktosemikropartikler 2497,5 mg + palminsyre 2,5 mg pulver og opløsningsmiddel til hætteglas med injektionsvæske, suspension Has manufactured dose form injektionsvæske false Inferred relationship Some
    galaktosemikropartikler 2497,5 mg + palminsyre 2,5 mg pulver og opløsningsmiddel til hætteglas med injektionsvæske, suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Contrast media (substance) false Inferred relationship Some
    galaktosemikropartikler 2497,5 mg + palminsyre 2,5 mg pulver og opløsningsmiddel til hætteglas med injektionsvæske, suspension Is a Product manufactured as parenteral dose form (product) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start